BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29383099)

  • 41. KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway.
    Guo Y; Chai B; Jia J; Yang M; Li Y; Zhang R; Wang S; Xu J
    Cell Biosci; 2021 Apr; 11(1):73. PubMed ID: 33858520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
    BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
    Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.
    Liu M; Jiang K; Lin G; Liu P; Yan Y; Ye T; Yao G; Barr MP; Liang D; Wang Y; Gong P; Meng S; Piao H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):165. PubMed ID: 30041665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frizzled-3 suppression overcomes multidrug chemoresistance by Wnt/β-catenin signaling pathway inhibition in hepatocellular carcinoma cells.
    Meng Z; Liu Q; Liu Y; Yang Y; Shao C; Zhang S
    J Chemother; 2023 Nov; 35(7):653-661. PubMed ID: 36843499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.
    Kim M; Lee HC; Tsedensodnom O; Hartley R; Lim YS; Yu E; Merle P; Wands JR
    J Hepatol; 2008 May; 48(5):780-91. PubMed ID: 18313787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
    Okabe H; Kinoshita H; Imai K; Nakagawa S; Higashi T; Arima K; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Ishiko T; Yoshizumi T; Beppu T; Monga SP; Baba H; Maehara Y
    PLoS One; 2016; 11(4):e0152695. PubMed ID: 27100093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
    Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
    Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
    Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
    Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
    J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
    Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP
    Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
    Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
    Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities.
    Gajos-Michniewicz A; Czyz M
    Genes Dis; 2024 Mar; 11(2):727-746. PubMed ID: 37692481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
    Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.